10-K: Chemed Reports 2025 Profit Decline Amid Rising Costs

Chemed Corporation's 2025 annual report reveals a 12.2% drop in net income and a 7.7% decrease in diluted EPS, despite a 4.1% increase in consolidated service revenues, driven by higher Medicare cap liability and operational expenses.

Summary

• Consolidated service revenues and sales increased by 4.1% to $2.53 billion in 2025, up from $2.43 billion in 2024.
• Net income decreased by 12.2% to $265.2 million in 2025, compared to $302.0 million in 2024.
• Diluted earnings per share (EPS) fell by 7.7% to $18.34 in 2025, from $19.89 in 2024.
• Adjusted EBITDA decreased by 8.8% to $458.7 million in 2025, with the adjusted EBITDA as a percentage of revenue declining to 18.1% from 20.7% in 2024.
• The VITAS segment's revenue grew by 6.5%, primarily due to a 5.2% increase in days-of-care and a 3.4% Medicare reimbursement rate increase, but was negatively impacted by acuity mix shift (-110 bps) and Medicare cap/contra revenue changes (-100 bps).
• The Roto-Rooter segment's revenue remained essentially flat, with plumbing revenue up 0.7% (3.6% job count increase offset by 2.9% price/mix decrease) and drain cleaning revenue down 2.4% (2.1% price/mix increase offset by 4.5% job count decrease).
• Roto-Rooter's excavation revenue increased by 4.8% and water restoration revenue by 6.9%.
• VITAS after-tax earnings decreased due to an $18.7 million increase in Medicare Cap liability and a $3.9 million increase in legal expenses.
• Roto-Rooter's net income was negatively impacted by a $5.3 million increase in casualty insurance expense and a 41.8% increase in implicit price concessions and credit memos related to the water restoration business.
• The company repurchased 932,500 shares of capital stock for $431.5 million in 2025, compared to 638,235 shares for $361.4 million in 2024.
• Cash provided by operating activities decreased by $29.2 million to $388.3 million in 2025.
• A cybersecurity attack on VITAS in October 2025 resulted in access to Protected Health Information (PHI), leading to a payment to a threat actor and subsequent strengthening of security measures; cyber insurance covered costs above a $500,000 deductible.
• An Administrative Law Judge (ALJ) ruled in favor of VITAS on February 3, 2025, regarding a $50.3 million Medicare Administrative Contractor (MAC) overpayment demand from August 2022, leading to a refund of previously deposited amounts by April 1, 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with a slightly negative sentiment due to the significant decline in net income and EPS, coupled with increased operational costs and the cybersecurity incident, despite overall revenue growth and successful resolution of a major regulatory audit.

Positives

• Consolidated service revenues and sales increased by 4.1% in 2025, demonstrating overall top-line growth.
• The VITAS segment achieved a 6.5% revenue increase, driven by a 5.2% rise in days-of-care and a 3.4% Medicare reimbursement rate increase.
• Roto-Rooter saw growth in its plumbing (0.7%), excavation (4.8%), and water restoration (6.9%) services.
• The successful appeal of the $50.3 million MAC overpayment decision for VITAS, with an ALJ ruling largely in the company's favor and a subsequent refund, resolved a significant regulatory liability.
• The company authorized an additional $300 million for its stock repurchase program in August 2025, indicating confidence in its valuation and commitment to shareholder returns.
• No long-term debt was outstanding at December 31, 2025, providing financial flexibility.

Negatives

• Consolidated net income decreased by 12.2% in 2025, indicating a significant decline in profitability.
• Diluted EPS decreased by 7.7% in 2025, reflecting lower per-share earnings.
• Adjusted EBITDA declined by 8.8% and its margin decreased from 20.7% to 18.1%, signaling reduced operational efficiency.
• VITAS after-tax earnings were negatively impacted by an $18.7 million increase in Medicare Cap liability and a $3.9 million increase in legal expenses.
• Roto-Rooter's revenue was essentially flat, and its net income was negatively affected by a $5.3 million increase in casualty insurance expense and a 41.8% increase in implicit price concessions and credit memos.
• A cybersecurity attack on VITAS in October 2025 led to unauthorized access to Protected Health Information (PHI) and required a payment to a threat actor, despite mitigation efforts and insurance coverage.
• Multiple class action lawsuits have been filed against VITAS as a result of the cyberattack, introducing potential future liabilities and defense costs.
• The current ratio decreased from 1.4 in 2024 to 1.1 in 2025, indicating a slight weakening of short-term liquidity.

Risks

• Intense competition in both the Roto-Rooter and VITAS segments could adversely affect business performance, especially with private equity investments in home services and the fragmented hospice market.
• Roto-Rooter's operations are subject to numerous federal, state, and local laws and regulations related to franchising, insurance, and licensing, with potential for fines and compliance costs.
• Loss of key management personnel or inability to hire and retain skilled employees (e.g., licensed plumbers, nurses, home health aides) could negatively impact growth and profitability for both segments.
• Cybersecurity threats, including sophisticated attacks and the increasing use of AI by threat actors, pose a significant risk to information technology systems, sensitive customer/patient data, and business operations, as evidenced by the October 2025 breach.
• VITAS is highly dependent on Medicare and Medicaid payments (over 95% of revenue), making it vulnerable to changes in reimbursement rates, payment methods, and increased scrutiny of claims (e.g., TPE program).
• Medicare payment limits or 'caps' (inpatient and per-beneficiary) could lead to future payment reductions or recoupments for VITAS hospices.
• Changes in laws and regulations regarding payments for hospice services and room and board for nursing home residents could reduce VITAS's net patient service revenue and profitability.
• Inability to maintain existing patient referral sources or establish new ones could adversely affect VITAS's growth and profitability, especially if the CMS Special Focus Program (SFP) is reinstituted.
• Extensive government regulation in the healthcare industry, including anti-kickback laws, HIPAA anti-fraud provisions, False Claims Acts, and Stark Law, exposes VITAS to potential legal actions, penalties, and compliance costs.
• VITAS's growth strategies, including expansion into new and existing markets, may not be successful due to challenges in identifying suitable markets, hiring qualified teams, obtaining certifications, and competing effectively.
• Liability claims, including professional liability and False Claims Act lawsuits, could have a material adverse effect on VITAS's financial condition and reputation, with insurance coverage potentially being inadequate.
• The concentration of VITAS's headquarters and significant operations in Florida increases exposure to natural disasters like hurricanes, which could impede billing, operations, and patient service.
• Restrictions and limitations in borrowing agreements could impact operating flexibility and the ability to incur additional debt or refinance existing debt.
• Environmental and safety compliance costs and liabilities, including historical contamination from former businesses, could increase expenses.
• Anti-takeover statutes and heightened antitrust scrutiny of healthcare mergers could make changes in control or future acquisitions more difficult.
• Issues associated with epidemics, pandemics, or similar public health concerns could adversely affect businesses through operational restrictions, changes in demand, increased costs, and labor shortages.
• Significant tariffs on products like steel for Roto-Rooter and pharmaceuticals for VITAS, or increases in vehicle-related costs, could increase expenses and decrease margins, especially since VITAS cannot pass these costs to patients due to reimbursement structures.

Future Outlook

The company anticipates that its operating income and cash flows will be sufficient to operate its business and meet commitments for the foreseeable future. It forecasts compliance with all debt covenants through fiscal year 2026. The company is monitoring the adoption and implementation of California's Climate Corporate Data Accountability Act (SB 253) and Greenhouse Gases Climate-Related Financial Risk (SB 261) and is preparing for compliance. The FASB's ASU 2024-03 on disaggregation of income statement expenses is effective for fiscal periods beginning December 15, 2026, and ASU 2025-06 on internal-use software is effective for annual periods beginning after December 15, 2027, with the company currently analyzing their impacts.

Management Comments

• Our employees are crucial to our success, and the attraction and retention of top talent, as well as the training and promotion of that talent, must be key focuses of our businesses.
• We continually evaluate cash utilization alternatives, including share repurchase, debt repurchase, acquisitions and increased dividends to determine the most beneficial use of available capital resources.
• We believe our cash flow from operating activities and our unused eligible lines of credit are sufficient to fund our obligations and operate our business in the near and long term.
• Management currently believes the cyber insurance limits are sufficient to cover all remaining costs from the October 2025 cybersecurity incident.

Industry Context

StockSavvy.ai notes that Chemed operates in two distinct, yet essential, service industries: hospice care (VITAS) and plumbing/drain cleaning (Roto-Rooter). The hospice industry is highly regulated and fragmented, with increasing scrutiny on claims and payment caps, as evidenced by VITAS's Medicare cap liability and past OIG audits. The home services market, where Roto-Rooter operates, is also competitive, with recent significant investments from private equity firms. Both segments face challenges in attracting and retaining skilled labor, a common issue across service industries. The increasing sophistication of cyberattacks, particularly against healthcare companies, highlights a broader industry trend of heightened digital risk.

Comparison to Industry Standards

• VITAS, as one of the nation's largest providers in a highly fragmented hospice industry, competes with numerous small, community-based hospices, as well as national/regional providers, hospitals, and nursing homes. Its ability to deliver quality, responsive services within Medicare's conditions of participation is a key differentiator.
• Roto-Rooter operates in a highly competitive and fragmented plumbing and drain cleaning market, primarily competing with local and regional firms. Its strong brand recognition, established since 1935, is a significant competitive advantage compared to smaller, less recognized local players.
• The 2.6% inflationary increase for Medicare reimbursement rates effective October 1, 2025, is a standard annual adjustment, but the filing highlights that these adjustments have historically been less than actual inflation, a common challenge for healthcare providers reliant on government programs.
• The nationwide shortage of qualified nurses and aides, impacting VITAS, is a well-documented industry-wide issue in healthcare, leading to increased wages and benefits for recruitment and retention across the sector.

Management Changes

Corporate Governance

Legal Proceedings

• VITAS was involved in an audit by the Office of the Inspector General's (OIG) Office of Audit Services (OAS) regarding elevated level-of-care hospice services, which led to a $50.3 million repayment demand from its Medicare Administrative Contractor (MAC) on August 29, 2022.
• An Administrative Law Judge (ALJ) ruled on February 3, 2025, that VITAS's care met Medicare's hospice standards for all but one claim appealed, leading to a reduction of the overpayment to a de minimis amount and a refund of previously deposited funds by April 1, 2025.
• Multiple class action lawsuits have been filed against VITAS alleging various causes of action and seeking damages resulting from the cybersecurity incident and data breach on October 24, 2025; the Company intends to defend against these allegations but cannot reasonably estimate the probability or range of loss at this time.

Stakeholder Impact

• Shareholders: Experienced a decrease in net income and diluted EPS, but benefited from continued share repurchase programs and quarterly cash dividends. The cybersecurity incident and related lawsuits introduce uncertainty.
• Employees: The company emphasizes attraction, retention, and training of talent. VITAS implemented a 'Difference Maker Program' with stay-bonuses to address healthcare worker shortages. Management changes occurred with promotions and a severance agreement for a former executive.
• Customers/Patients: VITAS continues to provide hospice and palliative care, and Roto-Rooter offers plumbing and drain cleaning services. The cybersecurity breach at VITAS exposed Protected Health Information (PHI) of current and former patients, potentially impacting trust and privacy.
• Suppliers/Creditors: The company has no long-term debt outstanding, indicating a strong position for creditors. VITAS relies on single vendors for pharmacy services and medical supplies, which could pose a risk if disruptions occur.
• Regulatory Authorities: The company is subject to extensive federal and state regulations, with ongoing compliance efforts and past legal proceedings (e.g., False Claims Act settlement, OIG audit). The cybersecurity incident required regulatory notifications.

Next Steps

• Continue to monitor and develop information technology networks and infrastructure to prevent, detect, address, and mitigate cybersecurity threats.
• Defend against multiple class action lawsuits filed against VITAS alleging damages from the October 2025 cybersecurity breach.
• Monitor the adoption and implementation of California's Climate Corporate Data Accountability Act (SB 253) and Greenhouse Gases Climate-Related Financial Risk (SB 261) and prepare for compliance.
• Finalize the impact of ASU 2024-03 (Disaggregation of Income Statement Expenses) for incorporation into footnote disclosures in the 2026 Annual Report on Form 10-K.
• Analyze the impact of ASU 2025-06 (Intangibles Goodwill and Other Internal Use Software) on consolidated financial statements.
• Continue the current share repurchase program, with $127.3 million of authorization remaining under the February 2011 program.

Key Dates

Recommendation

The filing presents a mixed financial picture for Chemed. While revenue growth in 2025 is positive, the significant decline in net income and EPS, driven by increased Medicare cap liability, legal expenses, and Roto-Rooter's operational cost increases, is a concern. The successful resolution of the $50.3 million MAC audit is a strong positive, removing a substantial contingent liability. However, the recent cybersecurity breach at VITAS and the ensuing class-action lawsuits introduce new, unquantifiable legal and reputational risks. The company's strong balance sheet with no long-term debt and ongoing share repurchases are supportive, but the profitability headwinds and new litigation warrant a cautious 'hold' stance until the full impact of these challenges becomes clearer.

Keywords

Hospice Care, Plumbing Services, Drain Cleaning, Water Restoration, SEC Filing, 10-K, Financial Performance, Revenue Growth, Net Income Decline, EPS, EBITDA, Medicare Reimbursement, Medicaid, Cybersecurity Breach, Regulatory Compliance, False Claims Act, Share Repurchase, Acquisitions, Healthcare Industry, Home Services, Risk Factors, Corporate Governance